Form 4: P&G COO Acquires Shares, Options in Compensation Grant

Procter & Gamble's Chief Operating Officer, Shailesh Jejurikar, acquired 22,849 restricted stock units and 105,581 stock options as part of compensation.

Summary

• Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble Co (PG), acquired 22,849 shares of Common Stock in the form of Restricted Stock Units (RSUs) on October 1, 2025, with a reported price of $0.
• These RSUs were awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
• Jejurikar also acquired 105,581 Stock Options (Right to Buy) on October 1, 2025, with an exercise price of $153.18 and a reported acquisition price of $0.
• The stock options become exercisable on September 29, 2028, and expire on October 1, 2035.
• Following these transactions, Jejurikar directly beneficially owns 50,885.3817 shares of Common Stock and 105,581 Stock Options.
• Indirect beneficial ownership includes 3,331.1419 shares through a Retirement Plan Trustee, 19,757 shares through the Sankhya S Jejurikar Revocable Trust, and 17,849 shares through the Shailesh Jejurikar Trust.

Sentiment

Score: 7

Explanation: The filing reports a routine grant of restricted stock units and stock options to a key executive, aligning management interests with shareholder value, which is generally viewed positively for corporate governance and long-term performance incentives.

Positives

• The acquisition of restricted stock units and stock options aligns the Chief Operating Officer's financial interests with the long-term performance of the company, incentivizing value creation for shareholders.
• The grants are part of a structured compensation plan, indicating a commitment to retaining and motivating key executives.

Future Outlook

The filing indicates future exercisability of stock options starting September 29, 2028, and their expiration on October 1, 2035, which are standard terms for long-term incentive compensation.

Industry Context

This filing represents a routine executive compensation event, common across large corporations, particularly in the consumer staples sector. Such grants are standard practice to align executive performance with shareholder interests over multi-year periods.

Comparison to Industry Standards

• The grant of restricted stock units and stock options as part of executive compensation is a common practice across large publicly traded companies, including peers in the consumer staples sector such as Unilever, Colgate-Palmolive, and Kimberly-Clark.
• These compensation structures are designed to align executive incentives with long-term shareholder value creation, a widely accepted corporate governance principle.

Related Party Transactions

• Indirect beneficial ownership through the Sankhya S Jejurikar Revocable Trust and Shailesh Jejurikar Trust, which are typically considered related party entities for reporting purposes.

Stakeholder Impact

• Shareholders: The compensation structure aims to align the Chief Operating Officer's incentives with shareholder value creation, potentially leading to improved long-term performance.
• Employees: No direct impact on the broader employee base is indicated by this specific filing.

Next Steps

• The restricted stock units will vest according to the terms of The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
• The stock options will become exercisable on September 29, 2028, and can be exercised until their expiration on October 1, 2035.

Key Dates

Recommendation

This Form 4 filing details a standard executive compensation grant of restricted stock units and stock options to the Chief Operating Officer. Such routine insider transactions, while aligning management incentives with shareholder interests, do not typically provide new fundamental information that would warrant a change in investment recommendation for Procter & Gamble.

Keywords

Procter & Gamble, PG, SEC Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Stock Options, Shailesh Jejurikar, COO